The opportunity within the Cell Therapy Manufacturing Market to grow at 12% CAGR till 2035, according to a market research report by Roots Analysis

Over the years, several advanced and innovative automation tools and technologies have been developed; these have been demonstrated to hold the potential for significant reduction in the cost associated with the manufacturing of advanced therapy medicinal products (such as cell therapy manufacturing), thereby, making such products more affordable. One such emerging concept, namely GMP-In-A Box, offers several advantages, including increased throughput, decreased idle time between batch runs and reduced manual labor. However, the delicate nature of steps involved in the cell therapy manufacturing process is known to hinder the overall automation process. Further, the lack of specialized infrastructure and limited expertise available in this domain are some of the known challenges impacting the growth of this segment.

Over the years, several advanced and innovative automation tools and technologies have been developed; these have been demonstrated to hold the potential for significant reduction in the cost associated with the manufacturing of advanced therapy medicinal products (such as cell therapy manufacturing), thereby, making such products more affordable. One such emerging concept, namely GMP-In-A Box, offers several advantages, including increased throughput, decreased idle time between batch runs and reduced manual labor. However, the delicate nature of steps involved in the cell therapy manufacturing process is known to hinder the overall automation process. Further, the lack of specialized infrastructure and limited expertise available in this domain are some of the known challenges impacting the growth of this segment.

To order this 649 page report, which features 245+ figures and 285+ tables, please visit https://www.rootsanalysis.com/reports/cell-therapy-manufacturing/285.html 

Key Market Insights

For more information, please visit https://www.rootsanalysis.com/reports/cell-therapy-manufacturing/285.html 

The financial opportunity associated with the cell therapy manufacturing market has been analyzed across the following segments:

The report also features inputs from eminent industry stakeholders, according to whom, the manufacturing of cell therapies is largely being outsourced due to exorbitant costs associated with the setting-up of in-house expertise. The report includes detailed transcripts of discussions held with the following experts:

The research includes profiles of key players (industry and non-industry;listed below), featuring a brief overview of the company / organization, along with details related to its manufacturing facilities, service portfolio, recent developments and an informed future outlook.

Key Questions Answered

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Overview

5. Regulatory Landscape

6. Roadmaps for Overcoming Challenges

7. Automation Technologies for Cell Therapy Manufacturing 

8. Profiles: Industry Players

9. Profiles: Non-Industry Players

10. Role of Non-Profit Organizations

11. Clinical Trial Analysis

12. Partnerships and Collaborations

13. Recent Expansions

14. Big Pharma Initiatives

15. Capacity Analysis

16. Demand Analysis

17. Cost Price Analysis

18. Make Versus Buy Decision Making Framework

19. Total Cost of Ownership

20. Market Sizing and Opportunity Analysis

21. Key Insights

22. SWOT Analysis

23. Concluding Remarks

24. Survey Analysis

25. Interview Transcripts

26. Appendix 1: Tabulated Data

27. Appendix 2: List of Companies and Organizations

For additional details, please visit https://www.rootsanalysis.com/reports/cell-therapy-manufacturing/285.html

You may also be interested in the following titles:

Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
gaurav.chaudhary@rootsanalysis.com

Logo: https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/the-opportunity-within-the-cell-therapy-manufacturing-market-to-grow-at-12-cagr-till-2035-according-to-a-market-research-report-by-roots-analysis-301925672.html